Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study
about
Weight change as a predictor of incidence and remission of insulin resistance.Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults.Chronic stress, inflammation, and glucose regulation in U.S. Hispanics from the HCHS/SOL Sociocultural Ancillary Study.Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortalityBalanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Macrovascular complication phenotypes in type 2 diabetic patients.Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.Blood glucose may be an alternative to cholesterol in CVD risk prediction charts.A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related componentsAssociation between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profilesTwo novel mutations identified in familial cases with Donohue syndromeImplications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice.Metabolic syndrome and diabetes are associated with low serum amylase in a Chinese asymptomatic population.
P2860
Q34744415-9BD2ABB9-455F-4088-88DB-D850DE156AE8Q36226381-C5F44820-4670-43D9-9DE6-02864D99D8E1Q36268836-63A2AD6C-D211-47CC-9B35-E2DB1150FEA7Q36281537-5213EB0F-7AB7-4B9E-B7FE-737F492C81E7Q36288833-6653D0CD-D29F-4564-AC0F-E5EDC44E5B37Q36411656-7D789DE0-4FDF-4C37-B223-D3EF8E970E5CQ36572131-A02FF4B7-1E79-490A-A9F3-0B66B1ADFA24Q36686775-72BBDC96-B92F-45CC-8B4B-4B66740EC259Q36689297-E96C0B1A-5041-4516-81AD-F3ED2CDF5430Q36701880-0F434A1B-6FD4-4298-B5E4-99BD30F16ECAQ36846587-1017EBED-5BA6-48C4-A709-99BED496552CQ37299343-FBA75495-5B0E-4FDA-B670-F1CA2349FD38Q37535785-EA031F29-2FB6-4D72-B35C-560825A23AAAQ38341934-02A3AB24-605D-49AF-877A-96114643043CQ50884915-6101AD2A-6F81-4CA6-8264-6BA134BD1A75Q51328077-A8235975-7C60-44D3-A3A3-2DA132F3615F
P2860
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Insulin resistance increases t ...... nown diabetes. the SMART study
@ast
Insulin resistance increases t ...... nown diabetes. the SMART study
@en
type
label
Insulin resistance increases t ...... nown diabetes. the SMART study
@ast
Insulin resistance increases t ...... nown diabetes. the SMART study
@en
prefLabel
Insulin resistance increases t ...... nown diabetes. the SMART study
@ast
Insulin resistance increases t ...... nown diabetes. the SMART study
@en
P2093
P2860
P356
P1476
Insulin resistance increases t ...... nown diabetes. the SMART study
@en
P2093
Annemarie M J Wassink
Frank L J Visseren
Petra M Gorter
SMART Study Group
Sandra N Verhagen
Yolanda van der Graaf
P2860
P2888
P356
10.1186/1475-2840-10-100
P407
P577
2011-11-21T00:00:00Z
P5875
P6179
1052479009